BPL027 Pill - white capsule/oblong
Pill with imprint BPL027 is White, Capsule/Oblong and has been identified as Flecainide Acetate 150 mg. It is supplied by Bayshore Pharmaceuticals LLC.
Flecainide is used in the treatment of Atrial Fibrillation; Supraventricular Tachycardia; Atrial Flutter; Wolff-Parkinson-White Syndrome; Ventricular Tachycardia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Flecainide 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BPL027
Flecainide Acetate
- Imprint
- BPL027
- Strength
- 150 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bayshore Pharmaceuticals LLC
- Manufacturer
- Beximco Pharmaceuticals Ltd.
- National Drug Code (NDC)
- 76385-0147
More about flecainide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (172)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: group I antiarrhythmics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
